- Stocks
- Capital Goods
- SKYBIOTECH
SKYBIOTECH share price
NSE: SKYBIOTECHCapital GoodsConglomerates
SKYBIOTECH at a glance
With a market capitalisation of ₹37 Cr, it ranks 3268th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Capital Goods sector; its industry is Conglomerates.
Its return on equity was −14.0% in FY26. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹2 Cr (+79.4% year on year) and net profit −₹0 Cr, on a consolidated basis. Promoters held 63.48% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹37 CrRank 3268 on NSE
- Price to book
- 3.69×FY26
- EPS (TTM)
- −₹6.53to Q4 FY26
- ROE
- −14.0%FY26
- ROCE
- −9.4%FY26
- Debt to equity
- 1.05FY26
- Net profit margin
- −15.7%FY26
- Book value / share
- ₹41.74FY26
Returns to 19 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | — | — | — | — | — |
SKYBIOTECH quarterly results
| Quarter | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr |
| Revenue YoY | — | — | — | — | +25.1% | +20.0% | −61.9% | +79.4% |
| Net profit | −₹1 Cr | −₹0 Cr | −₹0 Cr | −₹1 Cr | −₹0 Cr | −₹0 Cr | −₹0 Cr | −₹0 Cr |
| Net profit YoY | — | — | −136.4% | — | — | — | — | — |
| Net margin | −33.5% | −15.6% | −15.5% | −105.9% | −0.8% | −16.1% | −50.0% | −16.4% |
| EPS | −₹3.36 | −₹5.46 | −₹3.06 | −₹13.68 | ₹0.25 | −₹1.29 | −₹2.53 | −₹2.96 |
SKYBIOTECH financials
| Item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Revenue | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | — |
| Operating profit | −₹0 Cr | −₹0 Cr | −₹0 Cr | ₹2 Cr | ₹0 Cr | — |
| Net profit | −₹0 Cr | −₹0 Cr | −₹0 Cr | ₹2 Cr | ₹0 Cr | — |
| EPS (₹) | −₹0.46 | −₹0.36 | −₹2.32 | ₹3.67 | ₹1.50 | — |
| Cash from operations | — | — | — | — | −₹1 Cr | — |
| Total debt | — | — | — | — | ₹7 Cr | ₹8 Cr |
| Shareholders' equity | — | — | — | — | ₹9 Cr | ₹8 Cr |
SKYBIOTECH shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 63.48% | 63.48% | 63.48% | 63.48% | 63.48% | 63.48% |
| Non-institutions | 36.52% | 36.52% | 36.52% | 36.52% | 36.52% | 36.52% |
SKYBIOTECH vs peers
The listed Capital Goods companies nearest to SKYBIOTECH by market capitalisation.
Ask anything about SKYBIOTECH
Pivot answers on the live chart with evidence you can check, and tests strategies against SKYBIOTECH's own history. Try: “Why has SKYBIOTECH moved over the last three months?” · “Backtest a 50-day moving-average crossover on SKYBIOTECH over five years” · “Compare SKYBIOTECH with SSL on margins and valuation”
Frequently asked questions about SKYBIOTECH
What is the market cap of SKYBIOTECH?
SKYBIOTECH's market capitalisation is ₹37 Cr (₹37 Cr) at the 19 Oct 2026 close, ranking 3268th among the NSE companies Pivot tracks.
What is the ROE and ROCE of SKYBIOTECH?
Return on equity was −14.0% in FY26 and return on capital employed was −9.4% in FY26 (consolidated figures).
Is SKYBIOTECH a debt-free company?
No. SKYBIOTECH's debt-to-equity ratio was 1.05 in FY26, with total debt of ₹8 Cr.
What were SKYBIOTECH's latest quarterly results?
For Q4 FY26 (quarter ended 31 Mar 2026), SKYBIOTECH reported revenue of ₹2 Cr, +79.4% year on year, and net profit of −₹0 Cr.
What is the shareholding pattern of SKYBIOTECH?
As of 30 Jun 2026: promoters 63.48%, non-institutions 36.52%.
Who are SKYBIOTECH's competitors?
The listed Capital Goods companies closest to SKYBIOTECH by market cap are Share Samadhan, Storage Technol, Evans Electric, Landmark Global, Shreeshay Engin and Swastika Castal.
Is SKYBIOTECH a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out SKYBIOTECH's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on SKYBIOTECH against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 19 Oct 2026 (returns and ratios at the 19 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Capital Goods stocks · companies starting with S · all NSE stocks · this page as text